MARKs as modifiers of the PTEN pathway and methods of use

Details for Australian Patent Application No. 2004260036 (hide)

Owner Exelixis, Inc.

Inventors McGrath, Garth Joseph; Costa, Michael R.; Lickteig, Kim; Heuer, Timothy S.

Agent Davies Collison Cave

Pub. Number AU-A-2004260036

PCT Pub. Number WO2005/010148

Priority 60/479,768 19.06.03 US

Filing date 18 June 2004

Wipo publication date 3 February 2005

International Classifications

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/010148 Priority application(s): WO2005/010148

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260044-Subgroup B adenoviral vectors for treating disease

2004260029-Filtered calculation of sensor array induced phase angle independent from demodulation phase offset of phase generated carrier